Drug intelligence / Profile preview

pelargonium sidoides extract

Development stage
Phase 3
Lead developer
Schwabe
Administration
Oral
01

Overview

Pelargonium sidoides extract is an herbal drug preparation derived from the roots of the Pelargonium sidoides plant, which is native to South Africa. [16] It is widely used for treating acute respiratory tract infections, including acute bronchitis, sinusitis, the common cold, and tonsillitis. [3, 4] The primary standardized extract is known as EPs 7630, which is manufactured by Dr. Willmar Schwabe Pharmaceuticals. [24] The mechanism of action is multifactorial, involving immunomodulatory, antiviral, and antibacterial properties. [6, 7] It has been shown to modulate the immune system by inducing cytokines like interferon-β and TNF-alpha, stimulating natural killer cell activity, and increasing phagocytosis. [2, 21] Its antiviral effects include inhibiting viral replication and preventing viruses from attaching to host cells. [5, 8] Additionally, it exhibits antibacterial effects by preventing bacteria from adhering to host cells and possesses mucolytic properties by increasing ciliary beat frequency, which helps clear mucus from the respiratory tract. [2, 5, 16] The extract is available in various forms, including oral solutions (drops) and tablets. [3, 11]

Brand names
UmckaloaboLinctagonPELAFORCEKalobaZucol
Other names
South African GeraniumAfrican Geranium
02

Targets

IFN-β (Interferon beta)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on pelargonium sidoides extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pelargonium sidoides extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call